July 12, 2023 Comments Off on New patent for Glaxosmithkline drug ZEJULA Posted in: Patent Added Annual Drug Patent Expirations for ZEJULA Zejula is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from one supplier. There are six patents protecting…
The post New patent for Glaxosmithkline drug ZEJULA appeared first o…
July 11, 2023 Comments Off on New patent for Meridian Labs drug DOCETAXEL Posted in: Patent Added Annual Drug Patent Expirations for DOCETAXEL Docetaxel is a drug marketed by Accord Hlthcare, Actavis Llc, Amneal, Apotex Inc, Dfb Oncology Ltd, Dr Reddys, Eugia Pharma, Gland Pharma Ltd, Hengrui…
The post New patent for Meridian Labs drug DOCETAXEL ap…